Emerald Mutual Fund Advisers Trust Acer Therapeutics Inc. Transaction History

Emerald Mutual Fund Advisers Trust

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 31, 2019	SELL	$3.45 - $26.86 $431,250 - $3.36 Million	-125,000 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$18.0 - $32.83 $2.25 Million - $4.1 Million	125,000 New	125,000 $3.86 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.